![Critical link revealed between iron deficiency and a serious cardiovascular condition — Department of Physiology, Anatomy and Genetics (DPAG) Critical link revealed between iron deficiency and a serious cardiovascular condition — Department of Physiology, Anatomy and Genetics (DPAG)](https://www.dpag.ox.ac.uk/images/news-items/sll-lab-summary-slide.png)
Critical link revealed between iron deficiency and a serious cardiovascular condition — Department of Physiology, Anatomy and Genetics (DPAG)
![Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets | Circulation Research Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets | Circulation Research](https://www.ahajournals.org/cms/asset/34932e06-a5f2-4eac-9a46-e69d043f76d1/circresaha.122.321667.fig03.jpg)
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets | Circulation Research
![Cureus | Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited | Article Cureus | Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited | Article](https://assets.cureus.com/uploads/figure/file/257556/article_river_b6fe5fa074fb11ec8393a55dd2d4d7d8-Image-1-2-1-.png)
Cureus | Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited | Article
![Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management - Farmakis - 2017 - European Journal of Heart Failure - Wiley Online Library Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management - Farmakis - 2017 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/52d1ad8f-e9ef-4467-8418-2d387d77610d/ejhf708-fig-0004-m.jpg)
Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management - Farmakis - 2017 - European Journal of Heart Failure - Wiley Online Library
![Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial - The Lancet Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/asset/948bd6b3-def8-4340-b70f-d2367bacbad7/gr1.jpg)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial - The Lancet
Croí Heart & Stroke Charity - Thursday, November 26th, is Iron Deficiency Day! Croí is raising awareness about chronic heart failure and iron deficiency. ❤️ Iron is needed to carry oxygen in
![Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America - Journal of Cardiac Failure Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America - Journal of Cardiac Failure](https://onlinejcf.com/cms/attachment/51771b7e-3711-498a-8c8f-2992b27f2b38/gr1_lrg.jpg)
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America - Journal of Cardiac Failure
![Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet](https://www.thelancet.com/cms/attachment/c52db99f-d823-4c81-8c15-07c6f894aa06/gr1_lrg.jpg)
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet
![Ferric derisomaltose therapy and heart failure: implications and molecular insights | Nature Cardiovascular Research Ferric derisomaltose therapy and heart failure: implications and molecular insights | Nature Cardiovascular Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs44161-022-00202-w/MediaObjects/44161_2022_202_Fig1_HTML.png)
Ferric derisomaltose therapy and heart failure: implications and molecular insights | Nature Cardiovascular Research
![Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting | Internal and Emergency Medicine Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting | Internal and Emergency Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11739-020-02434-9/MediaObjects/11739_2020_2434_Fig1_HTML.png)
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting | Internal and Emergency Medicine
![Low iron levels may increase risk of heart disease, says study | Indiablooms - First Portal on Digital News Management Low iron levels may increase risk of heart disease, says study | Indiablooms - First Portal on Digital News Management](https://www.indiablooms.com/health_pic/2017/heart-1500215373.jpg)
Low iron levels may increase risk of heart disease, says study | Indiablooms - First Portal on Digital News Management
![Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology | Laboratory Investigation Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology | Laboratory Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Flabinvest.2017.111/MediaObjects/41374_2018_Article_BFlabinvest2017111_Fig3_HTML.jpg)